
Imilastin 500 mg/500 mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Imilastin 500 mg/500 mg Injection
The dual-antibiotic injection, Imilastin 500 mg/500 mg, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to curtail infection spread. Complete the prescribed treatment regimen, even with symptom improvement; missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions (redness, swelling, pain) may also occur, typically resolving spontaneously. Severe reactions, such as allergic responses (rash, itching, swelling, breathing difficulty), warrant immediate medical attention. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness.
Primary Ingredients of Imilastin 500 mg/500 mg Injection
There is no text provided to rewrite.
Uses of Imilastin 500 mg/500 mg Injection
Life-threatening bacterial infections
Major Benefits of Imilastin 500 mg/500 mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Imilastin 500 mg/500 mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imilastin 500 mg/500 mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Imilastin 500 mg/500 mg Injection works:
Imilastin 500 mg/500 mg Injection, a dual-drug formulation, comprises imipenem, a bacterial cell wall synthesis inhibitor, and cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibiotic action disrupts bacterial defenses, crucial for their viability. Cilastatin safeguards imipenem from premature enzymatic degradation (by dehydropeptidase I), thereby extending its therapeutic efficacy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imilastin 500 mg/500 mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Imilastin 500 mg/500 mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Imilastin 500 mg/500 mg Injection while breastfeeding is likely safe. Preliminary human studies indicate minimal risk to the infant.
DrivingUNSAFE
Administering Imilastin 500 mg/500 mg Injection might induce adverse reactions impacting driving capabilities. Certain medication side effects, including hallucinations (visual, auditory, or sensory), can impair some patients' driving abilities.
KidneyCAUTION
For individuals with impaired kidney function, administering Imilastin 500 mg/500 mg Injection requires careful consideration. Dosage modification of Imilastin 500 mg/500 mg Injection might be necessary. A physician's consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Imilastin 500 mg/500 mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Imilastin 500 mg/500 mg Injection :
Should you inadvertently skip a dose of the Imilastin 500 mg/500 mg Injection, seek medical advice from your physician.
Facts to Know About Imilastin 500 mg/500 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
